{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:07:38Z","timestamp":1790363258482,"version":"4.1.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hormone-related venous thromboembolism (VTE) is common and entails scenarios in which VTE occurs during exposure to exogenous or endogenous female sex hormones, typically estrogen and progestogen. For the management of hormone-related VTE, it is important to realize that many patients use these hormones for a vital purpose often strongly related to the patient's well-being and quality of life. In this review we discuss clinical cases of VTE related to hormonal contraceptive use and pregnancy to illustrate key considerations for clinical practice. We cover practice points for primary VTE treatment and detail the evidence on the risk of recurrent VTE and bleeding in this population. The potential value of thrombophilia testing is described, including \u201cwho, why, when, what, and how.\u201d We also discuss key aspects of shared decision-making for anticoagulant duration, including a reduced-dose anticoagulant strategy in hormone-related VTE.<\/jats:p>","DOI":"10.1182\/hematology.2024000593","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:06:07Z","timestamp":1733497567000},"page":"664-671","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":5,"title":["Hormone-related thrombosis: duration of anticoagulation, risk of recurrence, and the role of hypercoagulability testing"],"prefix":"10.1182","volume":"2024","author":[{"given":"Luuk J. J.","family":"Scheres","sequence":"first","affiliation":[{"name":"1 Department of Internal Medicine, Radboud university medical center, Nijmegen, the Netherlands"},{"name":"2 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Middeldorp","sequence":"additional","affiliation":[{"name":"1 Department of Internal Medicine, Radboud university medical center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"9","key":"2024121115403788600_hem2024000593C1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jth.14549","article-title":"Sex matters: practice 5P's when treating young women with venous thromboembolism","volume":"17","author":"Bistervels","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2024121115403788600_hem2024000593C2","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"2024121115403788600_hem2024000593C3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.blre.2018.08.001","article-title":"Everything the clinician needs to know about evidence-based anticoagulation in pregnancy","volume":"33","author":"Scheres","year":"2019","journal-title":"Blood Rev"},{"issue":"19","key":"2024121115403788600_hem2024000593C4","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"2024121115403788600_hem2024000593C5","doi-asserted-by":"crossref","first-page":"e12570","DOI":"10.1002\/rth2.12570","article-title":"Menstruation, anticoagulation, and contraception: VTE and uterine bleeding","volume":"5","author":"Samuelson Bannow","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"2024121115403788600_hem2024000593C6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/1471-0528.15388","article-title":"Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study","volume":"125","author":"Scheres","year":"2018","journal-title":"BJOG"},{"issue":"4","key":"2024121115403788600_hem2024000593C7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1160\/TH16-11-0874","article-title":"Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin","volume":"117","author":"Brekelmans","year":"2017","journal-title":"Thromb Haemost"},{"issue":"16","key":"2024121115403788600_hem2024000593C8","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1182\/blood.2022017101","article-title":"Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism","volume":"140","author":"Jong","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2024121115403788600_hem2024000593C9","doi-asserted-by":"crossref","first-page":"100072","DOI":"10.1016\/j.rpth.2023.100072","article-title":"How do anticoagulants impact menstrual bleeding and quality of life? The PERIOD study","volume":"7","author":"Patel","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"11","key":"2024121115403788600_hem2024000593C10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2024121115403788600_hem2024000593C11","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jtha.2024.03.014","article-title":"Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women","volume":"22","author":"Verlaan","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"20","key":"2024121115403788600_hem2024000593C12","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"2024121115403788600_hem2024000593C13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2024121115403788600_hem2024000593C14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2024121115403788600_hem2024000593C15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2006.06317.x","article-title":"The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis","volume":"135","author":"De Stefano","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"2024121115403788600_hem2024000593C16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1160\/TH08-04-0238","article-title":"Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism","volume":"100","author":"White","year":"2008","journal-title":"Thromb Haemost"},{"key":"2024121115403788600_hem2024000593C17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2018.05.005","article-title":"Prevention of venous thromboembolism in pregnant patients with a history of venous thromboembolic disease: a retrospective cohort study","volume":"167","author":"Lazo-Langner","year":"2018","journal-title":"Thromb Res"},{"issue":"22","key":"2024121115403788600_hem2024000593C18","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"issue":"10365","key":"2024121115403788600_hem2024000593C19","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(22)02128-6","article-title":"Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open- label, multicentre, randomised, controlled trial","volume":"400","author":"Bistervels","year":"2022","journal-title":"Lancet"},{"issue":"9383","key":"2024121115403788600_hem2024000593C20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"2024121115403788600_hem2024000593C21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/rth2.12101","article-title":"Current and future burden of venous thrombosis: not simply predictable","volume":"2","author":"Scheres","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"2024121115403788600_hem2024000593C22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"2024121115403788600_hem2024000593C23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2020.12.031","article-title":"Prediction models for recurrence and bleeding in patients with venous thromboembolism: a systematic review and critical appraisal","volume":"199","author":"Winter","year":"2021","journal-title":"Thromb Res"},{"issue":"5","key":"2024121115403788600_hem2024000593C24","first-page":"16492","article-title":"How to predict recurrent venous thromboembolism and bleeding? A review of recent advances and their implications","volume":"133","author":"Burggraaf","year":"2023","journal-title":"Pol Arch Intern Med"},{"issue":"5","key":"2024121115403788600_hem2024000593C25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/jth.15661","article-title":"Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: systematic review and meta-analysis","volume":"20","author":"Wiegers","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2024121115403788600_hem2024000593C26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bjh.18331","article-title":"Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: a systematic review and meta-analysis","volume":"199","author":"Abdulrehman","year":"2022","journal-title":"Br J Haematol"},{"issue":"22","key":"2024121115403788600_hem2024000593C27","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"issue":"8","key":"2024121115403788600_hem2024000593C28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"13","key":"2024121115403788600_hem2024000593C29","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"key":"2024121115403788600_hem2024000593C30","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"key":"2024121115403788600_hem2024000593C31","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"2024121115403788600_hem2024000593C32","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"issue":"9190","key":"2024121115403788600_hem2024000593C33","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(99)03132-3","article-title":"Risk of cardiovascular diseases associated with oral progestagen preparations with therapeutic indications","volume":"354","author":"Poulter","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"2024121115403788600_hem2024000593C34","doi-asserted-by":"crossref","first-page":"e12763","DOI":"10.1002\/rth2.12763","article-title":"Hormonal therapies and venous thrombosis: considerations for prevention and management","volume":"6","author":"LaVasseur","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"2024121115403788600_hem2024000593C35","first-page":"272","article-title":"Assessing and addressing the risk of venous thromboembolism across the spectrum of gender affirming care: a review","volume":"29","author":"Arrington-Sanders","year":"2023","journal-title":"Endocr Pract"},{"issue":"4","key":"2024121115403788600_hem2024000593C36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"2024121115403788600_hem2024000593C37","doi-asserted-by":"crossref","first-page":"d813","DOI":"10.1136\/bmj.d813","article-title":"Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis","volume":"342","author":"Douketis","year":"2011","journal-title":"BMJ"},{"issue":"19","key":"2024121115403788600_hem2024000593C38","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","article-title":"Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review","volume":"170","author":"Iorio","year":"2010","journal-title":"Arch Intern Med"},{"issue":"10","key":"2024121115403788600_hem2024000593C39","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7326\/M21-1094","article-title":"Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann Intern Med"},{"issue":"7","key":"2024121115403788600_hem2024000593C40","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1055\/a-1690-8728","article-title":"Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"122","author":"Khan","year":"2022","journal-title":"Thromb Haemost"},{"issue":"3","key":"2024121115403788600_hem2024000593C41","doi-asserted-by":"crossref","first-page":"102385","DOI":"10.1016\/j.rpth.2024.102385","article-title":"Testing for the lupus anticoagulant: the good, the bad, and the ugly","volume":"8","author":"Favaloro","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"11","key":"2024121115403788600_hem2024000593C42","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2024121115403788600_hem2024000593C43","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/664\/2346629\/664scheres.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/hematology\/article-pdf\/2024\/1\/664\/2346629\/664scheres.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:08:38Z","timestamp":1733947718000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2024\/1\/664\/526227\/Hormone-related-thrombosis-duration-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,6]]},"published-print":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1182\/hematology.2024000593","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,6]]},"published":{"date-parts":[[2024,12,6]]}}}